Dementia Discovery Fund

The Dementia Discovery Fund (DDF) operates as a specialized venture capital fund, exclusively investing in novel therapeutic development for dementia. It targets early-stage projects, from new target identification to translating biological insights into disease-modifying drugs. DDF actively invests in and builds biotech companies, addressing critical gaps for science-driven solutions.

DDF was established in 2015, formed from a collective recognition of the immense unmet medical need in dementia. Advised by SV Health Investors, the fund secured support from pharmaceutical companies, financial institutions, and charities. This partnership leverages SV Health Investors' extensive life sciences venture capital experience to accelerate groundbreaking research.

DDF serves patients by fostering the creation of new disease-modifying dementia treatments. The fund partners with entrepreneurs and innovators, providing strategic support and capital. DDF's vision is to alleviate the global health burden of dementia through a robust pipeline of effective therapies, significantly altering disease progression.